The sale of Juul vaping products will no longer be prohibited, according to a Tuesday announcement from the Food and Drug Administration (FDA). The organization claimed that “scientific issues” that require further investigation led to the administrative stay of its marketing denial decision against Juul. The FDA ordered the vaping business to remove its items, including its devices and nicotine liquid pods, from the market in June after deciding that Juul had not provided sufficient proof that its goods did not endanger public health.
The FDA stated on Twitter, “On July 5, 2022, FDA administratively stayed the marketing denial order. The agency has determined that there are scientific issues unique to the JUUL application that warrant additional review.” The agency also noted that “This administrative stay temporarily suspends the marketing denial order during the additional review but does not rescind it. Does not constitute authorization to market, sell, or ship JUUL products.”
One day after the FDA issued the ban on Juul’s vaping products, the U.S. Court of Appeals for the District of Columbia Circuit granted Juul a temporary stay. Separately, Juul has requested the FDA to postpone its ruling pending an appeal. Juul claims that the FDA processed its application improperly by failing to review more than 6,000 pages of data that were provided to the organization. The San Francisco-based company said in court filings that the FDA’s decision to enact the ban was motivated more by political than scientific considerations.
